iShares MSCI Switzerland ETF logo

iShares MSCI Switzerland ETF (0JER)

Market Closed
28 Aug, 15:30
LSE LSE
$
63. 65
-0.12
-0.1882%
$
1.4B Market Cap
4.07% Div Yield
1 Volume
$ 63.77
Previous Close
Add Transaction
Day Range
63.65 63.65
Year Range
54.05 65.49
Want to track 0JER and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

0JER closed Friday lower at $63.65, a decrease of -0.1882% from Thursday's close, completing a monthly increase of 0.8077% or $0.51. Over the past 12 months, 0JER stock gained 5.5031%.
0JER pays dividends to its shareholders, with the most recent payment made on Jun 18, 2026. The next estimated payment will be in In 9 months on Jun 18, 2027 for a total of $1.09045.
iShares MSCI Switzerland ETF has completed 1 stock splits, with the recent split occurring on Mar 28, 2018.
The company's stock is traded on 7 different exchanges and in various currencies, with the primary listing on ARCA (USD).

0JER Chart

People also search for

Mobius Investment Trust plc
177.34 GBX
+0.1921%
OSB
OSB Group Plc
515.35 GBX
+0.1652%
N91
Ninety One plc
210.2 GBX
-1.959%
iShares STOXX Europe Small 200 UCITS ETF (DE)
40.61
-0.264%
IHP
IntegraFin Holdings plc
389 GBX
-2.3839%
Switzerland Rejects Forced Labor Accusations After U.S. Imposes New Tariffs

Switzerland Rejects Forced Labor Accusations After U.S. Imposes New Tariffs

Switzerland refuted U.S. allegations over forced labor after the Trump administration imposed a new 12.5% tariff on imports of Swiss goods.

Wsj | 1 month ago
Swiss pharma hub Basel frets over population cap threat

Swiss pharma hub Basel frets over population cap threat

For decades, economic growth in Basel has outpaced that of Switzerland as its globe-straddling pharmaceutical and biotech industries have ​turned the city on the border with Germany and France into one of the most prosperous in Europe.

Reuters | 2 months ago
Swiss Biotech sector boosted by shift toward private funding, report says

Swiss Biotech sector boosted by shift toward private funding, report says

Switzerland's biotech industry shifted toward private financing in 2025 as funding from capital markets remained difficult ​to obtain and pharmaceutical companies sought out collaborative deals ‌with biotech firms, a report on the sector showed on Tuesday.

Reuters | 3 months ago

iShares MSCI Switzerland ETF (0JER) FAQ

What is the stock price today?

The current price is $63.65.

On which exchange is it traded?

iShares MSCI Switzerland ETF is listed on LSE.

What is its stock symbol?

The ticker symbol is 0JER.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 4.07%.

What is its market cap?

As of today, the market cap is 1.4B.

Has iShares MSCI Switzerland ETF ever had a stock split?

iShares MSCI Switzerland ETF had 1 splits and the recent split was on Mar 28, 2018.

iShares MSCI Switzerland ETF Profile

LSE Exchange
US Country

Overview

The fund in question is an investment vehicle that primarily focuses on replicating the performance of its underlying index, which tracks the large- and mid-cap segments of the Swiss equity market. By allocating at least 80% of its assets in the securities that make up the index and in other investments with similar economic characteristics, the fund aims to offer its investors a focused approach to participating in the Swiss equity space. It operates with a non-diversified strategy, meaning it may concentrate its investments more heavily in fewer issues than a diversified fund would. The underlying index itself is a free float-adjusted, market capitalization-weighted index, underscoring the fund's emphasis on mirroring the market movements and performance of substantial Swiss enterprises.

Products and Services

  • Component Securities Investments

    The fund invests a substantial portion of its assets directly in the securities that are included in its underlying index. These investments are chosen based on their ability to replicate the economic characteristics and performance of the large- and mid-cap segments of the Swiss equity market. This method allows the fund to closely track the index's performance.

  • Investments with Economic Characteristics Identical to Component Securities

    In addition to direct investments in component securities of the underlying index, the fund also allocates assets to other investments that have economic characteristics substantially identical to those component securities. This could include derivative contracts or other financial instruments that mimic the performance of the index's securities, providing another layer of strategy aimed at achieving the fund's investment objectives.

Contact Information

Address: 400 Howard Street
Phone: 1-800-474-2737